ESLA — ESTRELLA IMMUNOPHARMA INC
As of Q2 2026, 5 SEC-registered investment managers reported holding ESLA (ESTRELLA IMMUNOPHARMA INC) in their latest 13F filings, with a combined reported value of $279.80K across 269.04K shares. That is -51.9% by share count (-290.23K shares) versus the previous quarter, while reported value moved -52.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 added to existing stakes, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ESLA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 448.76K | $700.07K | 0.00% | Add |
| Wells Fargo & Co history | Q1 2026 | 264.39K | $280.25K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 141.32K | $146.97K | 0.00% | Reduce |
| Citadel Advisors history | Q4 2025 | 64.39K | $100.45K | 0.00% | Add |
| Marshall Wace history | Q4 2025 | 56.24K | $87.73K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 52.03K | $54.11K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 39.10K | $40.66K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 34.86K | $36.26K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 1.72K | $1.79K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q1 2025 | 23 | $21 | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 10 | $16 | 0.00% | Add |
| Morgan Stanley history | Q1 2026 | 1 | $1 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Wells Fargo & Co sold 264.39K sh · $280.25K
- Morgan Stanley sold 1 sh · $1
Fund Position History — shares by quarter (top 12 funds)
| Fund | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 56.22K | 58.21K | 58.21K | 76.56K | 93.42K | 100.17K | 103.34K | 101.49K | 109.81K | 157.49K | 141.32K |
| BlackRock Inc | — | — | — | 24.96K | 25.12K | 24.65K | 31.41K | 24.08K | 26.47K | 39.89K | 52.03K |
| Renaissance Technologies | — | — | — | — | — | — | — | 10.69K | 122.47K | 62.80K | 39.10K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | 19.62K | 19.62K | 34.86K |
| UBS Group AG | 303 | — | — | 6.52K | 65.17K | 41.03K | 72.77K | 50.35K | 3.19K | 15.08K | 1.72K |
| Citadel Advisors | — | — | — | 14.53K | — | 91.60K | 50.16K | 50.12K | 64.39K | — | — |
| Morgan Stanley | — | — | — | — | — | — | — | — | 11.10K | 1 | — |
| Bank of America Corp | — | — | 78 | 83 | 83 | 87 | 92 | 2 | 10 | — | — |
| Marshall Wace | — | — | — | — | — | — | — | — | 56.24K | — | — |
| Vanguard Group | — | — | — | 21.68K | 21.68K | 277.58K | 282.84K | 419.71K | 448.76K | — | — |
| Wells Fargo & Co | 73 | 74 | — | — | — | — | — | — | — | 264.39K | — |
| JPMorgan Chase & Co | — | — | 26 | 27 | 26 | 23 | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details